These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26068633)

  • 1. Symptomatic cardiac metastasis responding to pazopanib in a patient with renal cell carcinoma.
    Behzadigohar R; Rosenthal MA; Tran B
    Can J Urol; 2015 Jun; 22(3):7824-6. PubMed ID: 26068633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent renal cell carcinoma presenting as a solitary left ventricular mass.
    Wilde L; Mehrotra P; Hoffman-Censits J
    Can J Urol; 2017 Dec; 24(6):9145-9147. PubMed ID: 29260644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity.
    Schinzari G; Monterisi S; Signorelli D; Cona MS; Cassano A; Danza F; Barone C
    Tumori; 2014; 100(6):e298-300. PubMed ID: 25688515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged survival of a patient with papillary renal cell carcinoma and brain metastases using pazopanib.
    Jacobs C; Kim DW; Straka C; Timmerman RD; Brugarolas J
    J Clin Oncol; 2013 Mar; 31(7):e114-7. PubMed ID: 23319695
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromophobe renal cell carcinoma with sarcomatoid dedifferentiation treated with pazopanib: a case report.
    Matrana MR; Ng C; Rao P; Lim ZD; Tannir NM
    Clin Genitourin Cancer; 2011 Dec; 9(2):137-9. PubMed ID: 21831725
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal cell cancer metastases to esophagus and stomach successfully treated with radiotherapy and pazopanib.
    Cabezas-Camarero S; Puente J; Manzano A; Corona JA; González-Larriba JL; Bernal-Becerra I; Sotelo M; Díaz-Rubio E
    Anticancer Drugs; 2015 Jan; 26(1):112-6. PubMed ID: 25075797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report.
    Jeon SY; Lee NR; Yim CY
    BMC Nephrol; 2019 Jan; 20(1):1. PubMed ID: 30606155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac metastasis of renal cell carcinoma without inferior vena cava involvement: case report.
    Topçuoğlu M; Yeşilkaya Y; Kılınçer A
    Turk Kardiyol Dern Ars; 2013 Mar; 41(2):154-6. PubMed ID: 23666305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pazopanib in renal cell carcinoma.
    Sternberg CN
    Clin Adv Hematol Oncol; 2010 Apr; 8(4):232-3. PubMed ID: 20505644
    [No Abstract]   [Full Text] [Related]  

  • 10. Pazopanib for the treatment of metastatic renal cell carcinoma.
    Pick AM; Nystrom KK
    Clin Ther; 2012 Mar; 34(3):511-20. PubMed ID: 22341567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nursing considerations for patients receiving pazopanib for renal cell carcinoma.
    Becze E
    ONS Connect; 2012 Feb; 27(2):16-7. PubMed ID: 22375508
    [No Abstract]   [Full Text] [Related]  

  • 12. Uveal metastasis and myasthenia gravis in a patient with recurrent renal cell carcinoma treated with pazopanib.
    Jebb A; Hadden P; Broom RJ
    Clin Genitourin Cancer; 2014 Aug; 12(4):e143-6. PubMed ID: 24656526
    [No Abstract]   [Full Text] [Related]  

  • 13. Pazopanib for the treatment of renal cancer.
    Al-Marrawi MY; Rini B
    Expert Opin Pharmacother; 2011 May; 12(7):1171-89. PubMed ID: 21470066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nursing considerations with pazopanib therapy: focus on metastatic renal cell carcinoma.
    Bourdeanu L; Twardowski P; Pal SK
    Clin J Oncol Nurs; 2011 Oct; 15(5):513-7. PubMed ID: 21951737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pazopanib as third line therapy for metastatic renal cell carcinoma: clinical efficacy and temporal analysis of cytokine profile.
    Pal SK; Hossain DM; Zhang Q; Frankel PH; Jones JO; Carmichael C; Ruel C; Lau C; Kortylewski M
    J Urol; 2015 Apr; 193(4):1114-21. PubMed ID: 25286010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case report.
    Biasco E; Antonuzzo A; Cianci C; Derosa L; Marconcini R; Farnesi A; Galli L
    Tumori; 2014; 100(3):e83-6. PubMed ID: 25076257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pazopanib (Votrient) in the management of renal cell cancer and soft tissue sarcomas].
    Gennigens C; Jerusalem G
    Rev Med Liege; 2012; 67(7-8):437-42. PubMed ID: 22984765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A rare form of heart metastasis: hypernephroma. Successful surgical treatment].
    Minale C; Ulbricht LJ; Höler H; Köbberling J; Cramer BM; Schubert GE
    Z Kardiol; 1995 Aug; 84(8):643-7. PubMed ID: 7571771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good tolerability, long-term survival and easy management of side effects in a patient with metastatic renal cell carcinoma treated with pazopanib.
    Frascaroli M; Di Cesare P
    Tumori; 2014; 100(6):e301-4. PubMed ID: 25688516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior reversible encephalopathy syndrome induced by pazopanib for renal cell carcinoma.
    Asaithambi G; Peters BR; Hurliman E; Moran BP; Khan AS; Taylor RA
    J Clin Pharm Ther; 2013 Apr; 38(2):175-6. PubMed ID: 23210935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.